Evaluation of a daily practice composite score for the assessment of Crohn’s disease: the treatment impact of certolizumab pegol

B. G. Feagan; S. B. Hanauer; G. Coteur; S. Schreiber

首页> 外文期刊>Alimentary Pharmacology & Therapeutics >Evaluation of a daily practice composite score for the assessment of Crohn’s disease: the treatment impact of certolizumab pegol

【24h】

Evaluation of a daily practice composite score for the assessment of Crohn’s disease: the treatment impact of certolizumab pegol

机译：评估克罗恩病的日常实践综合评分：西妥珠单抗聚乙二醇乙二醇对治疗的影响

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Aliment Pharmacol Ther 2011; 33: 1143–1151

机译：Aliment Pharmacol Ther 2011； 33：1143-1115

著录项

来源
《Alimentary Pharmacology & Therapeutics》 |2011年第10期|1143-1151|共9页
作者
B. G. Feagan; S. B. Hanauer; G. Coteur; S. Schreiber;
展开▼
作者单位

Robarts Research Institute University of Western Ontario London ON Canada.;

University of Chicago Hospital Center Chicago IL USA.;

UCB Pharma Brussels Belgium.;

University Hospital Schleswig-Holstein Christian-Albrechts-University Kiel Germany.;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol. [J] . Feagan BG, Hanauer SB, Coteur G, Alimentary pharmacology & therapeutics. . 2011,第10期

机译：评估克罗恩病的日常实践综合评分的评估：certolizumab聚乙二醇的治疗效果。
2. COST-MINIMIZATION AND BUDGET IMPACT ANALYSIS OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF CROHN'S DISEASE FROM THE PERSPECTIVE OF THE BRAZILIAN PRIVATE HEALTHCARE SETTING [J] . Rosim R. P., Duva A. S., Ferraz Ballalai A. F., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：从巴西私人医疗环境视角下，克罗恩疾病治疗克罗恩病的成本最小化和预算分析
3. Endoscopic Scoring Systems in Crohn's Disease for Evaluation of Responsiveness to Treatment: Are we Ready for the Prime Time of Endoscopic Assessment? [J] . Buchner Anna M., Lichtenstein Gary R. The American Journal of Gastroenterology . 2017,第10期

机译：克罗恩病患中的内镜评分系统评估对治疗的反应性：我们是否准备好了内窥镜评估的主要时间？
4. Enteral Nutrition as Treatment Option for Crohn's Disease: In Kids Only? [C] . Frank M. Ruemmele, Benedicte Pigneur, Helene Gamier-Lengline Nestlé Nutrition Workshop . 2014

机译：肠内营养作为克罗恩病的治疗选择：仅在孩子们？
5. The Economic Evaluation of Early Intervention with Anti-TNF-α Treatments in Pediatric Crohn’s Disease [D] . Bashir, Naazish Sultana 2019

机译：小儿克罗恩病早期干预抗TNF-α治疗的经济评价
6. Is Certolizumab Pegol Safe and Effective in the Treatment of Patients with Moderate to Severe Crohn’s Disease? A Meta-analysis of Controlled Clinical Trials [O] . Shekoufeh Nikfar, Solmaz Ehteshami-Afshar, Mohammad Abdollahi 2013

机译：Certolizumab Pegol在中重度克罗恩病患者中是否安全有效？对照临床试验的荟萃分析
7. 9 ASSESSMENT OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF CROHN'S DISEASE IN PATIENTS FOR WHOM INFLIXIMAB TREATMENT WAS NOT SUCCESSFUL: OPEN-LABEL INDUCTION PRELIMINARY RESULTS FROM THE WELCOME STUDY [O] . S. Vermeire, M.T. Abreu, G. DHaens, 2008

机译：9评估extolizumab pegol在患者中治疗克罗恩病的患者患者，其中incriximab治疗不成功：开放标签归纳初步结果来自欢迎研究

Evaluation of a daily practice composite score for the assessment of Crohn’s disease: the treatment impact of certolizumab pegol

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅